News

STAT2d
GSK drug’s new approval sets up competition with Dupixent
Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud.
Sana: HIP-Modified Islet Cells To Possibly Change Scope Of Type 1 Diabetes Treatment
Discover upcoming breakthroughs in Type 1 Diabetes & B-cell disorder treatments, market growth to $24B by 2031, and key ...
The Hill1mon
America can’t afford to fall behind China in the race for biotech dominance
Among other steps to foster international cooperation with our friends and partners, the report recommends that Congress include biotech within the scope of the State Department’s International ...
Yahoo Finance1mon
VERAXA Biotech and Voyager Acquisition Corp. Announce Business Combination Agreement to Create Nasdaq-Listed Biopharmaceutical Company Advancing a Pipeline of Next-Generation ...
Upon closing of the transaction, VERAXA Biotech AG is expected to list on ... The Company has recently widened the scope of its AI-enabled technology platform and is now actively pursuing two ...
Reuters1mon
Trump health policy uncertainty sends biotech sector into deeper slump
LONDON, April 14 (Reuters) - Trump administration cuts across federal health agencies have sent shivers through a biotech industry already struggling through a prolonged downturn, increasing ...
The Boston Globe2mon
Unleased lab space. Plunging valuations. Layoffs. In Massachusetts, the biotech slump is taking its toll.
This was supposed to be the year of biotech’s comeback. At least that was the hope of many in the sector who started 2025 pointing to scientific advances and falling interest rates. Some foresaw ...